nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP1A2—Anagrelide—hematologic cancer	0.0557	0.0847	CbGbCtD
Cinacalcet—CYP2D6—Lomustine—hematologic cancer	0.0296	0.045	CbGbCtD
Cinacalcet—CYP1A2—Carmustine—hematologic cancer	0.0293	0.0445	CbGbCtD
Cinacalcet—CYP2D6—Idarubicin—hematologic cancer	0.0264	0.0401	CbGbCtD
Cinacalcet—CYP1A2—Methoxsalen—hematologic cancer	0.0249	0.0378	CbGbCtD
Cinacalcet—CYP1A2—Bortezomib—hematologic cancer	0.0237	0.036	CbGbCtD
Cinacalcet—CYP1A2—Daunorubicin—hematologic cancer	0.0227	0.0344	CbGbCtD
Cinacalcet—CYP2D6—Hydroxyurea—hematologic cancer	0.0224	0.0341	CbGbCtD
Cinacalcet—CYP1A2—Alitretinoin—hematologic cancer	0.0222	0.0337	CbGbCtD
Cinacalcet—CYP1A2—Thalidomide—hematologic cancer	0.0206	0.0314	CbGbCtD
Cinacalcet—CYP3A4—Bexarotene—hematologic cancer	0.0202	0.0308	CbGbCtD
Cinacalcet—CYP2D6—Bortezomib—hematologic cancer	0.0195	0.0297	CbGbCtD
Cinacalcet—CYP3A4—Lomustine—hematologic cancer	0.0188	0.0286	CbGbCtD
Cinacalcet—CYP3A4—Busulfan—hematologic cancer	0.0188	0.0286	CbGbCtD
Cinacalcet—CYP1A2—Dacarbazine—hematologic cancer	0.0177	0.027	CbGbCtD
Cinacalcet—CYP1A2—Imatinib—hematologic cancer	0.0174	0.0264	CbGbCtD
Cinacalcet—CYP3A4—Thiotepa—hematologic cancer	0.0168	0.0255	CbGbCtD
Cinacalcet—CYP2D6—Imatinib—hematologic cancer	0.0143	0.0217	CbGbCtD
Cinacalcet—CYP1A2—Dasatinib—hematologic cancer	0.0139	0.0212	CbGbCtD
Cinacalcet—CYP3A4—Methoxsalen—hematologic cancer	0.013	0.0198	CbGbCtD
Cinacalcet—CYP2D6—Nilotinib—hematologic cancer	0.013	0.0197	CbGbCtD
Cinacalcet—CYP2D6—Vinorelbine—hematologic cancer	0.0129	0.0196	CbGbCtD
Cinacalcet—CYP3A4—Bortezomib—hematologic cancer	0.0124	0.0189	CbGbCtD
Cinacalcet—CYP3A4—Daunorubicin—hematologic cancer	0.0119	0.018	CbGbCtD
Cinacalcet—CYP3A4—Cytarabine—hematologic cancer	0.0105	0.0159	CbGbCtD
Cinacalcet—CYP3A4—Teniposide—hematologic cancer	0.0103	0.0157	CbGbCtD
Cinacalcet—CYP3A4—Ifosfamide—hematologic cancer	0.00952	0.0145	CbGbCtD
Cinacalcet—CYP3A4—Imatinib—hematologic cancer	0.00909	0.0138	CbGbCtD
Cinacalcet—CYP1A2—Etoposide—hematologic cancer	0.00868	0.0132	CbGbCtD
Cinacalcet—CYP3A4—Ruxolitinib—hematologic cancer	0.00856	0.013	CbGbCtD
Cinacalcet—CYP3A4—Nilotinib—hematologic cancer	0.00826	0.0126	CbGbCtD
Cinacalcet—CYP3A4—Vinorelbine—hematologic cancer	0.00819	0.0125	CbGbCtD
Cinacalcet—CYP2D6—Vinblastine—hematologic cancer	0.00794	0.0121	CbGbCtD
Cinacalcet—CYP3A4—Triamcinolone—hematologic cancer	0.00749	0.0114	CbGbCtD
Cinacalcet—CYP3A4—Dasatinib—hematologic cancer	0.0073	0.0111	CbGbCtD
Cinacalcet—CYP3A4—Mitoxantrone—hematologic cancer	0.00721	0.011	CbGbCtD
Cinacalcet—CYP3A4—Betamethasone—hematologic cancer	0.00643	0.00977	CbGbCtD
Cinacalcet—CYP3A4—Prednisolone—hematologic cancer	0.00634	0.00964	CbGbCtD
Cinacalcet—CYP3A4—Prednisone—hematologic cancer	0.00599	0.0091	CbGbCtD
Cinacalcet—CYP2D6—Dexamethasone—hematologic cancer	0.00588	0.00894	CbGbCtD
Cinacalcet—CYP3A4—Irinotecan—hematologic cancer	0.00568	0.00863	CbGbCtD
Cinacalcet—CYP3A4—Vinblastine—hematologic cancer	0.00505	0.00767	CbGbCtD
Cinacalcet—CYP3A4—Vincristine—hematologic cancer	0.00496	0.00754	CbGbCtD
Cinacalcet—CYP2D6—Doxorubicin—hematologic cancer	0.00488	0.00742	CbGbCtD
Cinacalcet—CYP3A4—Etoposide—hematologic cancer	0.00455	0.00691	CbGbCtD
Cinacalcet—CYP3A4—Dexamethasone—hematologic cancer	0.00374	0.00568	CbGbCtD
Cinacalcet—CYP3A4—Doxorubicin—hematologic cancer	0.0031	0.00472	CbGbCtD
Cinacalcet—Rash—Ifosfamide—hematologic cancer	6.75e-05	0.000251	CcSEcCtD
Cinacalcet—Dermatitis—Ifosfamide—hematologic cancer	6.74e-05	0.00025	CcSEcCtD
Cinacalcet—Dizziness—Irinotecan—hematologic cancer	6.72e-05	0.00025	CcSEcCtD
Cinacalcet—Urticaria—Etoposide—hematologic cancer	6.71e-05	0.000249	CcSEcCtD
Cinacalcet—Body temperature increased—Etoposide—hematologic cancer	6.68e-05	0.000248	CcSEcCtD
Cinacalcet—Abdominal pain—Etoposide—hematologic cancer	6.68e-05	0.000248	CcSEcCtD
Cinacalcet—Vomiting—Vincristine—hematologic cancer	6.63e-05	0.000246	CcSEcCtD
Cinacalcet—Anorexia—Dexamethasone—hematologic cancer	6.63e-05	0.000246	CcSEcCtD
Cinacalcet—Anorexia—Betamethasone—hematologic cancer	6.63e-05	0.000246	CcSEcCtD
Cinacalcet—Urticaria—Prednisolone—hematologic cancer	6.62e-05	0.000246	CcSEcCtD
Cinacalcet—Asthenia—Cisplatin—hematologic cancer	6.62e-05	0.000246	CcSEcCtD
Cinacalcet—Fatigue—Triamcinolone—hematologic cancer	6.61e-05	0.000246	CcSEcCtD
Cinacalcet—Rash—Vincristine—hematologic cancer	6.58e-05	0.000244	CcSEcCtD
Cinacalcet—Dermatitis—Vincristine—hematologic cancer	6.57e-05	0.000244	CcSEcCtD
Cinacalcet—Oedema peripheral—Epirubicin—hematologic cancer	6.57e-05	0.000244	CcSEcCtD
Cinacalcet—Headache—Vincristine—hematologic cancer	6.53e-05	0.000243	CcSEcCtD
Cinacalcet—Hypotension—Betamethasone—hematologic cancer	6.5e-05	0.000241	CcSEcCtD
Cinacalcet—Hypotension—Dexamethasone—hematologic cancer	6.5e-05	0.000241	CcSEcCtD
Cinacalcet—Nausea—Carmustine—hematologic cancer	6.49e-05	0.000241	CcSEcCtD
Cinacalcet—Vomiting—Mitoxantrone—hematologic cancer	6.46e-05	0.00024	CcSEcCtD
Cinacalcet—Vomiting—Irinotecan—hematologic cancer	6.46e-05	0.00024	CcSEcCtD
Cinacalcet—Immune system disorder—Methotrexate—hematologic cancer	6.43e-05	0.000239	CcSEcCtD
Cinacalcet—Nausea—Alitretinoin—hematologic cancer	6.43e-05	0.000239	CcSEcCtD
Cinacalcet—Convulsion—Prednisone—hematologic cancer	6.43e-05	0.000239	CcSEcCtD
Cinacalcet—Hypertension—Prednisone—hematologic cancer	6.41e-05	0.000238	CcSEcCtD
Cinacalcet—Rash—Mitoxantrone—hematologic cancer	6.4e-05	0.000238	CcSEcCtD
Cinacalcet—Rash—Irinotecan—hematologic cancer	6.4e-05	0.000238	CcSEcCtD
Cinacalcet—Dermatitis—Irinotecan—hematologic cancer	6.4e-05	0.000238	CcSEcCtD
Cinacalcet—Dermatitis—Mitoxantrone—hematologic cancer	6.4e-05	0.000238	CcSEcCtD
Cinacalcet—Headache—Mitoxantrone—hematologic cancer	6.36e-05	0.000236	CcSEcCtD
Cinacalcet—Headache—Irinotecan—hematologic cancer	6.36e-05	0.000236	CcSEcCtD
Cinacalcet—Nausea—Ifosfamide—hematologic cancer	6.35e-05	0.000236	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	6.34e-05	0.000235	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Betamethasone—hematologic cancer	6.34e-05	0.000235	CcSEcCtD
Cinacalcet—Arthralgia—Prednisone—hematologic cancer	6.32e-05	0.000235	CcSEcCtD
Cinacalcet—Myalgia—Prednisone—hematologic cancer	6.32e-05	0.000235	CcSEcCtD
Cinacalcet—Diarrhoea—Cisplatin—hematologic cancer	6.31e-05	0.000235	CcSEcCtD
Cinacalcet—Vomiting—Gemcitabine—hematologic cancer	6.29e-05	0.000234	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	6.27e-05	0.000233	CcSEcCtD
Cinacalcet—Paraesthesia—Betamethasone—hematologic cancer	6.24e-05	0.000232	CcSEcCtD
Cinacalcet—Paraesthesia—Dexamethasone—hematologic cancer	6.24e-05	0.000232	CcSEcCtD
Cinacalcet—Rash—Gemcitabine—hematologic cancer	6.24e-05	0.000232	CcSEcCtD
Cinacalcet—Dermatitis—Gemcitabine—hematologic cancer	6.23e-05	0.000232	CcSEcCtD
Cinacalcet—Hypersensitivity—Etoposide—hematologic cancer	6.23e-05	0.000231	CcSEcCtD
Cinacalcet—Malnutrition—Methotrexate—hematologic cancer	6.2e-05	0.00023	CcSEcCtD
Cinacalcet—Headache—Gemcitabine—hematologic cancer	6.2e-05	0.00023	CcSEcCtD
Cinacalcet—Nausea—Vincristine—hematologic cancer	6.2e-05	0.00023	CcSEcCtD
Cinacalcet—Hypersensitivity—Prednisolone—hematologic cancer	6.14e-05	0.000228	CcSEcCtD
Cinacalcet—Dyspepsia—Betamethasone—hematologic cancer	6.12e-05	0.000227	CcSEcCtD
Cinacalcet—Dyspepsia—Dexamethasone—hematologic cancer	6.12e-05	0.000227	CcSEcCtD
Cinacalcet—Urticaria—Triamcinolone—hematologic cancer	6.09e-05	0.000226	CcSEcCtD
Cinacalcet—Oedema peripheral—Doxorubicin—hematologic cancer	6.08e-05	0.000226	CcSEcCtD
Cinacalcet—Asthenia—Etoposide—hematologic cancer	6.06e-05	0.000225	CcSEcCtD
Cinacalcet—Body temperature increased—Triamcinolone—hematologic cancer	6.06e-05	0.000225	CcSEcCtD
Cinacalcet—Decreased appetite—Betamethasone—hematologic cancer	6.04e-05	0.000225	CcSEcCtD
Cinacalcet—Decreased appetite—Dexamethasone—hematologic cancer	6.04e-05	0.000225	CcSEcCtD
Cinacalcet—Nausea—Irinotecan—hematologic cancer	6.03e-05	0.000224	CcSEcCtD
Cinacalcet—Nausea—Mitoxantrone—hematologic cancer	6.03e-05	0.000224	CcSEcCtD
Cinacalcet—Immune system disorder—Epirubicin—hematologic cancer	6.02e-05	0.000224	CcSEcCtD
Cinacalcet—Infection—Prednisone—hematologic cancer	6.02e-05	0.000224	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6e-05	0.000223	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Betamethasone—hematologic cancer	6e-05	0.000223	CcSEcCtD
Cinacalcet—Fatigue—Betamethasone—hematologic cancer	6e-05	0.000223	CcSEcCtD
Cinacalcet—Fatigue—Dexamethasone—hematologic cancer	6e-05	0.000223	CcSEcCtD
Cinacalcet—Pruritus—Etoposide—hematologic cancer	5.98e-05	0.000222	CcSEcCtD
Cinacalcet—Arrhythmia—Epirubicin—hematologic cancer	5.96e-05	0.000221	CcSEcCtD
Cinacalcet—Nervous system disorder—Prednisone—hematologic cancer	5.94e-05	0.000221	CcSEcCtD
Cinacalcet—Skin disorder—Prednisone—hematologic cancer	5.88e-05	0.000219	CcSEcCtD
Cinacalcet—Nausea—Gemcitabine—hematologic cancer	5.88e-05	0.000218	CcSEcCtD
Cinacalcet—Vomiting—Cisplatin—hematologic cancer	5.86e-05	0.000218	CcSEcCtD
Cinacalcet—Rash—Cisplatin—hematologic cancer	5.82e-05	0.000216	CcSEcCtD
Cinacalcet—Dermatitis—Cisplatin—hematologic cancer	5.81e-05	0.000216	CcSEcCtD
Cinacalcet—Malnutrition—Epirubicin—hematologic cancer	5.8e-05	0.000216	CcSEcCtD
Cinacalcet—Diarrhoea—Etoposide—hematologic cancer	5.78e-05	0.000215	CcSEcCtD
Cinacalcet—Anorexia—Prednisone—hematologic cancer	5.77e-05	0.000215	CcSEcCtD
Cinacalcet—Anaemia—Methotrexate—hematologic cancer	5.73e-05	0.000213	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.69e-05	0.000211	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Betamethasone—hematologic cancer	5.69e-05	0.000211	CcSEcCtD
Cinacalcet—Hypersensitivity—Triamcinolone—hematologic cancer	5.65e-05	0.00021	CcSEcCtD
Cinacalcet—Dizziness—Etoposide—hematologic cancer	5.59e-05	0.000208	CcSEcCtD
Cinacalcet—Muscle spasms—Epirubicin—hematologic cancer	5.58e-05	0.000207	CcSEcCtD
Cinacalcet—Immune system disorder—Doxorubicin—hematologic cancer	5.57e-05	0.000207	CcSEcCtD
Cinacalcet—Urticaria—Dexamethasone—hematologic cancer	5.52e-05	0.000205	CcSEcCtD
Cinacalcet—Urticaria—Betamethasone—hematologic cancer	5.52e-05	0.000205	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.52e-05	0.000205	CcSEcCtD
Cinacalcet—Dizziness—Prednisolone—hematologic cancer	5.51e-05	0.000205	CcSEcCtD
Cinacalcet—Arrhythmia—Doxorubicin—hematologic cancer	5.51e-05	0.000205	CcSEcCtD
Cinacalcet—Asthenia—Triamcinolone—hematologic cancer	5.5e-05	0.000204	CcSEcCtD
Cinacalcet—Abdominal pain—Dexamethasone—hematologic cancer	5.5e-05	0.000204	CcSEcCtD
Cinacalcet—Body temperature increased—Betamethasone—hematologic cancer	5.5e-05	0.000204	CcSEcCtD
Cinacalcet—Body temperature increased—Dexamethasone—hematologic cancer	5.5e-05	0.000204	CcSEcCtD
Cinacalcet—Abdominal pain—Betamethasone—hematologic cancer	5.5e-05	0.000204	CcSEcCtD
Cinacalcet—Nausea—Cisplatin—hematologic cancer	5.48e-05	0.000204	CcSEcCtD
Cinacalcet—Paraesthesia—Prednisone—hematologic cancer	5.44e-05	0.000202	CcSEcCtD
Cinacalcet—Pruritus—Triamcinolone—hematologic cancer	5.42e-05	0.000202	CcSEcCtD
Cinacalcet—Cough—Methotrexate—hematologic cancer	5.41e-05	0.000201	CcSEcCtD
Cinacalcet—Convulsion—Methotrexate—hematologic cancer	5.37e-05	0.0002	CcSEcCtD
Cinacalcet—Vomiting—Etoposide—hematologic cancer	5.37e-05	0.0002	CcSEcCtD
Cinacalcet—Malnutrition—Doxorubicin—hematologic cancer	5.37e-05	0.0002	CcSEcCtD
Cinacalcet—Anaemia—Epirubicin—hematologic cancer	5.36e-05	0.000199	CcSEcCtD
Cinacalcet—Dyspepsia—Prednisone—hematologic cancer	5.33e-05	0.000198	CcSEcCtD
Cinacalcet—Rash—Etoposide—hematologic cancer	5.33e-05	0.000198	CcSEcCtD
Cinacalcet—Dermatitis—Etoposide—hematologic cancer	5.32e-05	0.000198	CcSEcCtD
Cinacalcet—Headache—Etoposide—hematologic cancer	5.29e-05	0.000197	CcSEcCtD
Cinacalcet—Chest pain—Methotrexate—hematologic cancer	5.28e-05	0.000196	CcSEcCtD
Cinacalcet—Arthralgia—Methotrexate—hematologic cancer	5.28e-05	0.000196	CcSEcCtD
Cinacalcet—Myalgia—Methotrexate—hematologic cancer	5.28e-05	0.000196	CcSEcCtD
Cinacalcet—Decreased appetite—Prednisone—hematologic cancer	5.26e-05	0.000196	CcSEcCtD
Cinacalcet—Rash—Prednisolone—hematologic cancer	5.25e-05	0.000195	CcSEcCtD
Cinacalcet—Dermatitis—Prednisolone—hematologic cancer	5.25e-05	0.000195	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.24e-05	0.000195	CcSEcCtD
Cinacalcet—Fatigue—Prednisone—hematologic cancer	5.22e-05	0.000194	CcSEcCtD
Cinacalcet—Headache—Prednisolone—hematologic cancer	5.22e-05	0.000194	CcSEcCtD
Cinacalcet—Constipation—Prednisone—hematologic cancer	5.18e-05	0.000192	CcSEcCtD
Cinacalcet—Muscle spasms—Doxorubicin—hematologic cancer	5.16e-05	0.000192	CcSEcCtD
Cinacalcet—Dizziness—Triamcinolone—hematologic cancer	5.07e-05	0.000188	CcSEcCtD
Cinacalcet—Cough—Epirubicin—hematologic cancer	5.06e-05	0.000188	CcSEcCtD
Cinacalcet—Convulsion—Epirubicin—hematologic cancer	5.03e-05	0.000187	CcSEcCtD
Cinacalcet—Infection—Methotrexate—hematologic cancer	5.03e-05	0.000187	CcSEcCtD
Cinacalcet—Nausea—Etoposide—hematologic cancer	5.02e-05	0.000187	CcSEcCtD
Cinacalcet—Hypertension—Epirubicin—hematologic cancer	5.01e-05	0.000186	CcSEcCtD
Cinacalcet—Asthenia—Dexamethasone—hematologic cancer	4.99e-05	0.000185	CcSEcCtD
Cinacalcet—Asthenia—Betamethasone—hematologic cancer	4.99e-05	0.000185	CcSEcCtD
Cinacalcet—Nervous system disorder—Methotrexate—hematologic cancer	4.96e-05	0.000184	CcSEcCtD
Cinacalcet—Anaemia—Doxorubicin—hematologic cancer	4.96e-05	0.000184	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Prednisone—hematologic cancer	4.95e-05	0.000184	CcSEcCtD
Cinacalcet—Nausea—Prednisolone—hematologic cancer	4.95e-05	0.000184	CcSEcCtD
Cinacalcet—Arthralgia—Epirubicin—hematologic cancer	4.94e-05	0.000184	CcSEcCtD
Cinacalcet—Chest pain—Epirubicin—hematologic cancer	4.94e-05	0.000184	CcSEcCtD
Cinacalcet—Myalgia—Epirubicin—hematologic cancer	4.94e-05	0.000184	CcSEcCtD
Cinacalcet—Pruritus—Dexamethasone—hematologic cancer	4.92e-05	0.000183	CcSEcCtD
Cinacalcet—Pruritus—Betamethasone—hematologic cancer	4.92e-05	0.000183	CcSEcCtD
Cinacalcet—Skin disorder—Methotrexate—hematologic cancer	4.92e-05	0.000183	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.91e-05	0.000182	CcSEcCtD
Cinacalcet—Vomiting—Triamcinolone—hematologic cancer	4.87e-05	0.000181	CcSEcCtD
Cinacalcet—Rash—Triamcinolone—hematologic cancer	4.83e-05	0.00018	CcSEcCtD
Cinacalcet—Dermatitis—Triamcinolone—hematologic cancer	4.83e-05	0.000179	CcSEcCtD
Cinacalcet—Anorexia—Methotrexate—hematologic cancer	4.82e-05	0.000179	CcSEcCtD
Cinacalcet—Urticaria—Prednisone—hematologic cancer	4.81e-05	0.000179	CcSEcCtD
Cinacalcet—Headache—Triamcinolone—hematologic cancer	4.8e-05	0.000178	CcSEcCtD
Cinacalcet—Body temperature increased—Prednisone—hematologic cancer	4.79e-05	0.000178	CcSEcCtD
Cinacalcet—Abdominal pain—Prednisone—hematologic cancer	4.79e-05	0.000178	CcSEcCtD
Cinacalcet—Diarrhoea—Dexamethasone—hematologic cancer	4.76e-05	0.000177	CcSEcCtD
Cinacalcet—Diarrhoea—Betamethasone—hematologic cancer	4.76e-05	0.000177	CcSEcCtD
Cinacalcet—Hypotension—Methotrexate—hematologic cancer	4.73e-05	0.000176	CcSEcCtD
Cinacalcet—Infection—Epirubicin—hematologic cancer	4.71e-05	0.000175	CcSEcCtD
Cinacalcet—Cough—Doxorubicin—hematologic cancer	4.69e-05	0.000174	CcSEcCtD
Cinacalcet—Convulsion—Doxorubicin—hematologic cancer	4.65e-05	0.000173	CcSEcCtD
Cinacalcet—Nervous system disorder—Epirubicin—hematologic cancer	4.64e-05	0.000173	CcSEcCtD
Cinacalcet—Hypertension—Doxorubicin—hematologic cancer	4.64e-05	0.000172	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.61e-05	0.000171	CcSEcCtD
Cinacalcet—Skin disorder—Epirubicin—hematologic cancer	4.6e-05	0.000171	CcSEcCtD
Cinacalcet—Dizziness—Betamethasone—hematologic cancer	4.6e-05	0.000171	CcSEcCtD
Cinacalcet—Dizziness—Dexamethasone—hematologic cancer	4.6e-05	0.000171	CcSEcCtD
Cinacalcet—Arthralgia—Doxorubicin—hematologic cancer	4.57e-05	0.00017	CcSEcCtD
Cinacalcet—Chest pain—Doxorubicin—hematologic cancer	4.57e-05	0.00017	CcSEcCtD
Cinacalcet—Myalgia—Doxorubicin—hematologic cancer	4.57e-05	0.00017	CcSEcCtD
Cinacalcet—Nausea—Triamcinolone—hematologic cancer	4.55e-05	0.000169	CcSEcCtD
Cinacalcet—Paraesthesia—Methotrexate—hematologic cancer	4.54e-05	0.000169	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.54e-05	0.000169	CcSEcCtD
Cinacalcet—Anorexia—Epirubicin—hematologic cancer	4.51e-05	0.000168	CcSEcCtD
Cinacalcet—Dyspnoea—Methotrexate—hematologic cancer	4.51e-05	0.000168	CcSEcCtD
Cinacalcet—Hypersensitivity—Prednisone—hematologic cancer	4.46e-05	0.000166	CcSEcCtD
Cinacalcet—Dyspepsia—Methotrexate—hematologic cancer	4.46e-05	0.000166	CcSEcCtD
Cinacalcet—Hypotension—Epirubicin—hematologic cancer	4.43e-05	0.000164	CcSEcCtD
Cinacalcet—Vomiting—Dexamethasone—hematologic cancer	4.42e-05	0.000164	CcSEcCtD
Cinacalcet—Vomiting—Betamethasone—hematologic cancer	4.42e-05	0.000164	CcSEcCtD
Cinacalcet—Decreased appetite—Methotrexate—hematologic cancer	4.4e-05	0.000164	CcSEcCtD
Cinacalcet—Rash—Betamethasone—hematologic cancer	4.38e-05	0.000163	CcSEcCtD
Cinacalcet—Rash—Dexamethasone—hematologic cancer	4.38e-05	0.000163	CcSEcCtD
Cinacalcet—Dermatitis—Dexamethasone—hematologic cancer	4.38e-05	0.000163	CcSEcCtD
Cinacalcet—Dermatitis—Betamethasone—hematologic cancer	4.38e-05	0.000163	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.37e-05	0.000162	CcSEcCtD
Cinacalcet—Fatigue—Methotrexate—hematologic cancer	4.36e-05	0.000162	CcSEcCtD
Cinacalcet—Headache—Betamethasone—hematologic cancer	4.36e-05	0.000162	CcSEcCtD
Cinacalcet—Headache—Dexamethasone—hematologic cancer	4.36e-05	0.000162	CcSEcCtD
Cinacalcet—Infection—Doxorubicin—hematologic cancer	4.35e-05	0.000162	CcSEcCtD
Cinacalcet—Asthenia—Prednisone—hematologic cancer	4.34e-05	0.000161	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.32e-05	0.00016	CcSEcCtD
Cinacalcet—Nervous system disorder—Doxorubicin—hematologic cancer	4.3e-05	0.00016	CcSEcCtD
Cinacalcet—Pruritus—Prednisone—hematologic cancer	4.28e-05	0.000159	CcSEcCtD
Cinacalcet—Skin disorder—Doxorubicin—hematologic cancer	4.26e-05	0.000158	CcSEcCtD
Cinacalcet—Paraesthesia—Epirubicin—hematologic cancer	4.25e-05	0.000158	CcSEcCtD
Cinacalcet—Dyspnoea—Epirubicin—hematologic cancer	4.22e-05	0.000157	CcSEcCtD
Cinacalcet—Anorexia—Doxorubicin—hematologic cancer	4.18e-05	0.000155	CcSEcCtD
Cinacalcet—Dyspepsia—Epirubicin—hematologic cancer	4.17e-05	0.000155	CcSEcCtD
Cinacalcet—Diarrhoea—Prednisone—hematologic cancer	4.14e-05	0.000154	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Methotrexate—hematologic cancer	4.14e-05	0.000154	CcSEcCtD
Cinacalcet—Nausea—Betamethasone—hematologic cancer	4.13e-05	0.000154	CcSEcCtD
Cinacalcet—Nausea—Dexamethasone—hematologic cancer	4.13e-05	0.000154	CcSEcCtD
Cinacalcet—Decreased appetite—Epirubicin—hematologic cancer	4.12e-05	0.000153	CcSEcCtD
Cinacalcet—Hypotension—Doxorubicin—hematologic cancer	4.1e-05	0.000152	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.09e-05	0.000152	CcSEcCtD
Cinacalcet—Fatigue—Epirubicin—hematologic cancer	4.08e-05	0.000152	CcSEcCtD
Cinacalcet—Constipation—Epirubicin—hematologic cancer	4.05e-05	0.000151	CcSEcCtD
Cinacalcet—Urticaria—Methotrexate—hematologic cancer	4.02e-05	0.000149	CcSEcCtD
Cinacalcet—Dizziness—Prednisone—hematologic cancer	4e-05	0.000149	CcSEcCtD
Cinacalcet—Body temperature increased—Methotrexate—hematologic cancer	4e-05	0.000149	CcSEcCtD
Cinacalcet—Abdominal pain—Methotrexate—hematologic cancer	4e-05	0.000149	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.99e-05	0.000148	CcSEcCtD
Cinacalcet—Paraesthesia—Doxorubicin—hematologic cancer	3.94e-05	0.000146	CcSEcCtD
Cinacalcet—Dyspnoea—Doxorubicin—hematologic cancer	3.91e-05	0.000145	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Epirubicin—hematologic cancer	3.87e-05	0.000144	CcSEcCtD
Cinacalcet—Dyspepsia—Doxorubicin—hematologic cancer	3.86e-05	0.000143	CcSEcCtD
Cinacalcet—Vomiting—Prednisone—hematologic cancer	3.85e-05	0.000143	CcSEcCtD
Cinacalcet—Rash—Prednisone—hematologic cancer	3.82e-05	0.000142	CcSEcCtD
Cinacalcet—Dermatitis—Prednisone—hematologic cancer	3.81e-05	0.000142	CcSEcCtD
Cinacalcet—Decreased appetite—Doxorubicin—hematologic cancer	3.81e-05	0.000142	CcSEcCtD
Cinacalcet—Headache—Prednisone—hematologic cancer	3.79e-05	0.000141	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	3.79e-05	0.000519	CbGpPWpGaD
Cinacalcet—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.78e-05	0.000141	CcSEcCtD
Cinacalcet—Fatigue—Doxorubicin—hematologic cancer	3.78e-05	0.00014	CcSEcCtD
Cinacalcet—Urticaria—Epirubicin—hematologic cancer	3.76e-05	0.00014	CcSEcCtD
Cinacalcet—Constipation—Doxorubicin—hematologic cancer	3.75e-05	0.000139	CcSEcCtD
Cinacalcet—Body temperature increased—Epirubicin—hematologic cancer	3.74e-05	0.000139	CcSEcCtD
Cinacalcet—Abdominal pain—Epirubicin—hematologic cancer	3.74e-05	0.000139	CcSEcCtD
Cinacalcet—Hypersensitivity—Methotrexate—hematologic cancer	3.73e-05	0.000139	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—MAP2K1—hematologic cancer	3.7e-05	0.000507	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CD—hematologic cancer	3.68e-05	0.000504	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	3.64e-05	0.000499	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CA—hematologic cancer	3.64e-05	0.000499	CbGpPWpGaD
Cinacalcet—Asthenia—Methotrexate—hematologic cancer	3.63e-05	0.000135	CcSEcCtD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	3.63e-05	0.000497	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—KRAS—hematologic cancer	3.6e-05	0.000493	CbGpPWpGaD
Cinacalcet—Nausea—Prednisone—hematologic cancer	3.6e-05	0.000134	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.58e-05	0.000133	CcSEcCtD
Cinacalcet—Pruritus—Methotrexate—hematologic cancer	3.58e-05	0.000133	CcSEcCtD
Cinacalcet—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	3.55e-05	0.000486	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	3.53e-05	0.000483	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—FGF2—hematologic cancer	3.52e-05	0.000482	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	3.52e-05	0.000482	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	3.5e-05	0.000479	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Epirubicin—hematologic cancer	3.49e-05	0.00013	CcSEcCtD
Cinacalcet—Urticaria—Doxorubicin—hematologic cancer	3.48e-05	0.000129	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—PIK3R1—hematologic cancer	3.47e-05	0.000475	CbGpPWpGaD
Cinacalcet—Body temperature increased—Doxorubicin—hematologic cancer	3.46e-05	0.000129	CcSEcCtD
Cinacalcet—Abdominal pain—Doxorubicin—hematologic cancer	3.46e-05	0.000129	CcSEcCtD
Cinacalcet—Diarrhoea—Methotrexate—hematologic cancer	3.46e-05	0.000129	CcSEcCtD
Cinacalcet—Asthenia—Epirubicin—hematologic cancer	3.4e-05	0.000126	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—JAK2—hematologic cancer	3.37e-05	0.000462	CbGpPWpGaD
Cinacalcet—Pruritus—Epirubicin—hematologic cancer	3.35e-05	0.000125	CcSEcCtD
Cinacalcet—Dizziness—Methotrexate—hematologic cancer	3.35e-05	0.000124	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—PIK3CA—hematologic cancer	3.31e-05	0.000453	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MDM2—hematologic cancer	3.29e-05	0.000451	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	3.29e-05	0.00045	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	3.29e-05	0.00045	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	3.27e-05	0.000448	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	3.26e-05	0.000447	CbGpPWpGaD
Cinacalcet—Diarrhoea—Epirubicin—hematologic cancer	3.24e-05	0.00012	CcSEcCtD
Cinacalcet—Hypersensitivity—Doxorubicin—hematologic cancer	3.23e-05	0.00012	CcSEcCtD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	3.23e-05	0.000442	CbGpPWpGaD
Cinacalcet—Vomiting—Methotrexate—hematologic cancer	3.22e-05	0.00012	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—MTOR—hematologic cancer	3.21e-05	0.000439	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CB—hematologic cancer	3.21e-05	0.000439	CbGpPWpGaD
Cinacalcet—Rash—Methotrexate—hematologic cancer	3.19e-05	0.000119	CcSEcCtD
Cinacalcet—Dermatitis—Methotrexate—hematologic cancer	3.19e-05	0.000118	CcSEcCtD
Cinacalcet—Headache—Methotrexate—hematologic cancer	3.17e-05	0.000118	CcSEcCtD
Cinacalcet—Asthenia—Doxorubicin—hematologic cancer	3.14e-05	0.000117	CcSEcCtD
Cinacalcet—Dizziness—Epirubicin—hematologic cancer	3.13e-05	0.000116	CcSEcCtD
Cinacalcet—Pruritus—Doxorubicin—hematologic cancer	3.1e-05	0.000115	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—HRAS—hematologic cancer	3.06e-05	0.000419	CbGpPWpGaD
Cinacalcet—Vomiting—Epirubicin—hematologic cancer	3.01e-05	0.000112	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CDKN1B—hematologic cancer	3.01e-05	0.000412	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	3.01e-05	0.000412	CbGpPWpGaD
Cinacalcet—Nausea—Methotrexate—hematologic cancer	3.01e-05	0.000112	CcSEcCtD
Cinacalcet—Diarrhoea—Doxorubicin—hematologic cancer	3e-05	0.000111	CcSEcCtD
Cinacalcet—Rash—Epirubicin—hematologic cancer	2.99e-05	0.000111	CcSEcCtD
Cinacalcet—Dermatitis—Epirubicin—hematologic cancer	2.98e-05	0.000111	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—AKT1—hematologic cancer	2.98e-05	0.000407	CbGpPWpGaD
Cinacalcet—Headache—Epirubicin—hematologic cancer	2.97e-05	0.00011	CcSEcCtD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	2.97e-05	0.000406	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PHYH—hematologic cancer	2.96e-05	0.000405	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—FTCD—hematologic cancer	2.96e-05	0.000405	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GMPS—hematologic cancer	2.96e-05	0.000405	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	2.96e-05	0.000405	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CASP3—hematologic cancer	2.95e-05	0.000404	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL2—hematologic cancer	2.94e-05	0.000403	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL6—hematologic cancer	2.93e-05	0.000401	CbGpPWpGaD
Cinacalcet—Dizziness—Doxorubicin—hematologic cancer	2.9e-05	0.000108	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CCND1—hematologic cancer	2.87e-05	0.000393	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—JUN—hematologic cancer	2.86e-05	0.000392	CbGpPWpGaD
Cinacalcet—Nausea—Epirubicin—hematologic cancer	2.81e-05	0.000105	CcSEcCtD
Cinacalcet—Vomiting—Doxorubicin—hematologic cancer	2.79e-05	0.000104	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CDKN1A—hematologic cancer	2.78e-05	0.00038	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	2.77e-05	0.00038	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTEN—hematologic cancer	2.77e-05	0.000379	CbGpPWpGaD
Cinacalcet—Rash—Doxorubicin—hematologic cancer	2.76e-05	0.000103	CcSEcCtD
Cinacalcet—Dermatitis—Doxorubicin—hematologic cancer	2.76e-05	0.000103	CcSEcCtD
Cinacalcet—Headache—Doxorubicin—hematologic cancer	2.75e-05	0.000102	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—MAPK8—hematologic cancer	2.71e-05	0.000371	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SMPD3—hematologic cancer	2.71e-05	0.000371	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—AKT1—hematologic cancer	2.7e-05	0.00037	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EP300—hematologic cancer	2.64e-05	0.000362	CbGpPWpGaD
Cinacalcet—Nausea—Doxorubicin—hematologic cancer	2.6e-05	9.67e-05	CcSEcCtD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.59e-05	0.000354	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SRC—hematologic cancer	2.57e-05	0.000352	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.53e-05	0.000346	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GMPS—hematologic cancer	2.51e-05	0.000343	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—FTCD—hematologic cancer	2.51e-05	0.000343	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PHYH—hematologic cancer	2.51e-05	0.000343	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—hematologic cancer	2.5e-05	0.000343	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.49e-05	0.000341	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.48e-05	0.00034	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—STAT3—hematologic cancer	2.48e-05	0.000339	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NRAS—hematologic cancer	2.47e-05	0.000338	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—DCK—hematologic cancer	2.37e-05	0.000324	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ASNS—hematologic cancer	2.37e-05	0.000324	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—B3GAT1—hematologic cancer	2.37e-05	0.000324	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAPK3—hematologic cancer	2.37e-05	0.000324	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.36e-05	0.000324	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.34e-05	0.00032	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.32e-05	0.000318	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MYC—hematologic cancer	2.3e-05	0.000315	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TGFB1—hematologic cancer	2.3e-05	0.000314	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SMPD3—hematologic cancer	2.29e-05	0.000314	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.29e-05	0.000313	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.29e-05	0.000313	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HDC—hematologic cancer	2.24e-05	0.000307	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.14e-05	0.000293	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KRAS—hematologic cancer	2.13e-05	0.000291	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.08e-05	0.000285	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CDA—hematologic cancer	2.05e-05	0.000281	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ASNS—hematologic cancer	2e-05	0.000275	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—B3GAT1—hematologic cancer	2e-05	0.000275	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—DCK—hematologic cancer	2e-05	0.000275	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PC—hematologic cancer	1.98e-05	0.00027	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.96e-05	0.000268	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CA—hematologic cancer	1.95e-05	0.000268	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PHYH—hematologic cancer	1.94e-05	0.000265	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GMPS—hematologic cancer	1.94e-05	0.000265	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—FTCD—hematologic cancer	1.94e-05	0.000265	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.91e-05	0.000261	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GBA—hematologic cancer	1.91e-05	0.000261	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HDC—hematologic cancer	1.9e-05	0.00026	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TP53—hematologic cancer	1.89e-05	0.000259	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HRAS—hematologic cancer	1.81e-05	0.000248	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.77e-05	0.000243	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.77e-05	0.000242	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MTAP—hematologic cancer	1.74e-05	0.000239	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CDA—hematologic cancer	1.74e-05	0.000238	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL6—hematologic cancer	1.73e-05	0.000237	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PC—hematologic cancer	1.67e-05	0.000229	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GBA—hematologic cancer	1.62e-05	0.000221	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC35B2—hematologic cancer	1.62e-05	0.000221	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—AKT1—hematologic cancer	1.6e-05	0.000219	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—FHL2—hematologic cancer	1.56e-05	0.000213	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ASNS—hematologic cancer	1.55e-05	0.000212	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.55e-05	0.000212	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—DCK—hematologic cancer	1.55e-05	0.000212	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AGRN—hematologic cancer	1.53e-05	0.000209	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MTAP—hematologic cancer	1.48e-05	0.000202	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HDC—hematologic cancer	1.47e-05	0.000201	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—IDH2—hematologic cancer	1.45e-05	0.000198	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HMMR—hematologic cancer	1.45e-05	0.000198	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.36e-05	0.000186	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CDA—hematologic cancer	1.34e-05	0.000184	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CA9—hematologic cancer	1.32e-05	0.000181	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ACP5—hematologic cancer	1.32e-05	0.000181	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—FHL2—hematologic cancer	1.32e-05	0.00018	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.31e-05	0.000179	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AGRN—hematologic cancer	1.29e-05	0.000177	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PC—hematologic cancer	1.29e-05	0.000177	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GBA—hematologic cancer	1.25e-05	0.000171	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.25e-05	0.000171	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—IDH1—hematologic cancer	1.24e-05	0.00017	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.23e-05	0.000168	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.23e-05	0.000168	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TXN—hematologic cancer	1.23e-05	0.000168	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HMMR—hematologic cancer	1.22e-05	0.000168	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—IDH2—hematologic cancer	1.22e-05	0.000168	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.2e-05	0.000165	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.16e-05	0.000158	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.15e-05	0.000158	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ARNTL—hematologic cancer	1.15e-05	0.000158	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MTAP—hematologic cancer	1.14e-05	0.000156	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.12e-05	0.000154	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.12e-05	0.000154	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CA9—hematologic cancer	1.12e-05	0.000153	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ACP5—hematologic cancer	1.12e-05	0.000153	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NCOR2—hematologic cancer	1.11e-05	0.000151	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.1e-05	0.00015	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NUP98—hematologic cancer	1.06e-05	0.000145	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—IDH1—hematologic cancer	1.05e-05	0.000144	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TXN—hematologic cancer	1.04e-05	0.000143	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTO1—hematologic cancer	1.04e-05	0.000143	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ABCC3—hematologic cancer	1.04e-05	0.000143	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.03e-05	0.000141	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.03e-05	0.000141	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NUP214—hematologic cancer	1.02e-05	0.00014	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SPHK1—hematologic cancer	1.02e-05	0.00014	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—FHL2—hematologic cancer	1.02e-05	0.000139	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ABCG2—hematologic cancer	1e-05	0.000137	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MTR—hematologic cancer	1e-05	0.000137	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AGRN—hematologic cancer	9.97e-06	0.000137	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ENO2—hematologic cancer	9.83e-06	0.000135	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—UGT1A1—hematologic cancer	9.79e-06	0.000134	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTT1—hematologic cancer	9.53e-06	0.000131	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CRABP1—hematologic cancer	9.52e-06	0.00013	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC22A1—hematologic cancer	9.52e-06	0.00013	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HMMR—hematologic cancer	9.45e-06	0.000129	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—IDH2—hematologic cancer	9.45e-06	0.000129	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SDC1—hematologic cancer	9.32e-06	0.000128	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ALOX5—hematologic cancer	9.28e-06	0.000127	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NUP98—hematologic cancer	8.99e-06	0.000123	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ARNTL—hematologic cancer	8.89e-06	0.000122	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ADCY7—hematologic cancer	8.73e-06	0.000119	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NCOA3—hematologic cancer	8.73e-06	0.000119	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NUP214—hematologic cancer	8.67e-06	0.000119	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CA9—hematologic cancer	8.65e-06	0.000118	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ACP5—hematologic cancer	8.65e-06	0.000118	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.58e-06	0.000117	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NCOR2—hematologic cancer	8.53e-06	0.000117	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ABCG2—hematologic cancer	8.49e-06	0.000116	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MTR—hematologic cancer	8.49e-06	0.000116	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ENO2—hematologic cancer	8.33e-06	0.000114	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—IDH1—hematologic cancer	8.13e-06	0.000111	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTT1—hematologic cancer	8.07e-06	0.000111	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TXN—hematologic cancer	8.04e-06	0.00011	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ABCC3—hematologic cancer	8.04e-06	0.00011	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTO1—hematologic cancer	8.04e-06	0.00011	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.95e-06	0.000109	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NQO1—hematologic cancer	7.92e-06	0.000108	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CD44—hematologic cancer	7.92e-06	0.000108	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SDC1—hematologic cancer	7.89e-06	0.000108	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.87e-06	0.000108	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—UGT1A1—hematologic cancer	7.56e-06	0.000103	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.54e-06	0.000103	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYCS—hematologic cancer	7.5e-06	0.000103	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	7.45e-06	0.000102	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.44e-06	0.000102	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CRABP1—hematologic cancer	7.35e-06	0.000101	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC22A1—hematologic cancer	7.35e-06	0.000101	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.16e-06	9.81e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.12e-06	9.75e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NUP98—hematologic cancer	6.94e-06	9.5e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.74e-06	9.22e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.74e-06	9.22e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CD44—hematologic cancer	6.71e-06	9.19e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NQO1—hematologic cancer	6.71e-06	9.19e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NUP214—hematologic cancer	6.69e-06	9.16e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTP1—hematologic cancer	6.61e-06	9.05e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.57e-06	9e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.55e-06	8.97e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MTR—hematologic cancer	6.55e-06	8.97e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ENO2—hematologic cancer	6.43e-06	8.8e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYCS—hematologic cancer	6.35e-06	8.69e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	6.31e-06	8.64e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ABCB1—hematologic cancer	6.25e-06	8.56e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.23e-06	8.53e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SDC1—hematologic cancer	6.09e-06	8.34e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTM1—hematologic cancer	6.07e-06	8.31e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NCOR1—hematologic cancer	6.07e-06	8.31e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.68e-06	7.77e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTP1—hematologic cancer	5.6e-06	7.66e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.42e-06	7.41e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MTHFR—hematologic cancer	5.37e-06	7.35e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ABCB1—hematologic cancer	5.3e-06	7.25e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CD44—hematologic cancer	5.18e-06	7.09e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NQO1—hematologic cancer	5.18e-06	7.09e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NCOR1—hematologic cancer	5.14e-06	7.04e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTM1—hematologic cancer	5.14e-06	7.04e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYCS—hematologic cancer	4.9e-06	6.71e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.87e-06	6.67e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MTHFR—hematologic cancer	4.55e-06	6.22e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CG—hematologic cancer	4.51e-06	6.17e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.32e-06	5.91e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CREBBP—hematologic cancer	4.18e-06	5.72e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.09e-06	5.6e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.01e-06	5.48e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.97e-06	5.44e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.97e-06	5.44e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.96e-06	5.43e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ALB—hematologic cancer	3.91e-06	5.36e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3.82e-06	5.23e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3R1—hematologic cancer	3.74e-06	5.12e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CREBBP—hematologic cancer	3.54e-06	4.85e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.51e-06	4.8e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CB—hematologic cancer	3.45e-06	4.73e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CD—hematologic cancer	3.36e-06	4.6e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ALB—hematologic cancer	3.31e-06	4.54e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3R1—hematologic cancer	3.17e-06	4.34e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTEN—hematologic cancer	2.99e-06	4.09e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.95e-06	4.04e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.93e-06	4.01e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—EP300—hematologic cancer	2.85e-06	3.9e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.73e-06	3.74e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.59e-06	3.55e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ALB—hematologic cancer	2.56e-06	3.5e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTEN—hematologic cancer	2.53e-06	3.46e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.45e-06	3.35e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—EP300—hematologic cancer	2.41e-06	3.3e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.26e-06	3.09e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.11e-06	2.88e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTEN—hematologic cancer	1.95e-06	2.67e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—EP300—hematologic cancer	1.86e-06	2.55e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.78e-06	2.44e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AKT1—hematologic cancer	1.72e-06	2.36e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AKT1—hematologic cancer	1.46e-06	2e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.38e-06	1.89e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AKT1—hematologic cancer	1.12e-06	1.54e-05	CbGpPWpGaD
